Technical Analysis for TYME - Tyme Technologies, Inc.

Grade Last Price % Change Price Change
grade D 1.26 4.13% 0.05
TYME closed up 4.13 percent on Wednesday, February 26, 2020, on 38 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical TYME trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 200 DMA Bearish 4.13%
Down 3 Days in a Row Weakness 4.13%
Down 4 Days in a Row Weakness 4.13%
Lower Bollinger Band Touch Weakness 4.13%
200 DMA Support Bullish -3.82%
Down 3 Days in a Row Weakness -3.82%
20 DMA Resistance Bearish -6.67%
50 DMA Resistance Bearish -6.67%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Tyme Technologies, Inc., formerly Global Group Enterprises Corp., conducts majority of its research and development activities and other business operations, through its subsidiary, Tyme Inc. (Tyme). Tyme is a clinical-stage biopharmaceutical company. Tyme is focused on the development and commercialization of highly targeted cancer therapeutics with a range of oncology indications. The Company's another subsidiary, Luminant Biosciences, LLC, conducts the initial research and development of the Company's therapeutic platform. The Company is formulating its regulatory and drug development program for its lead drug candidate, SM-88, and working towards the initiation of its Phase II clinical trial. The Company is also evaluating the expansion of its Phase II program to other types of cancer. The Company has not generated any revenue.
Biopharmaceutical Cancer Life Sciences Drug Development Cancer Therapeutics Millennium Pharmaceuticals Takeda Pharmaceutical Company

Is TYME a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.54
52 Week Low 0.92
Average Volume 585,594
200-Day Moving Average 1.28
50-Day Moving Average 1.41
20-Day Moving Average 1.35
10-Day Moving Average 1.29
Average True Range 0.12
ADX 17.42
+DI 18.02
-DI 24.35
Chandelier Exit (Long, 3 ATRs ) 1.28
Chandelier Exit (Short, 3 ATRs ) 1.52
Upper Bollinger Band 1.51
Lower Bollinger Band 1.19
Percent B (%b) 0.21
BandWidth 23.93
MACD Line -0.06
MACD Signal Line -0.05
MACD Histogram -0.011
Fundamentals Value
Market Cap 112.54 Million
Num Shares 89.3 Million
EPS -0.14
Price-to-Earnings (P/E) Ratio -9.00
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.37
Resistance 3 (R3) 1.35 1.31 1.35
Resistance 2 (R2) 1.31 1.28 1.31 1.34
Resistance 1 (R1) 1.28 1.26 1.30 1.30 1.34
Pivot Point 1.24 1.24 1.24 1.24 1.24
Support 1 (S1) 1.21 1.21 1.23 1.23 1.18
Support 2 (S2) 1.17 1.19 1.17 1.18
Support 3 (S3) 1.14 1.17 1.17
Support 4 (S4) 1.16